UK Markets open in 6 hrs 53 mins

Insights on the Parenteral Nutrition Global Market to 2027 - Focus on Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals

·7-min read

Dublin, Dec. 22, 2021 (GLOBE NEWSWIRE) -- The "Global Parenteral Nutrition Market By Nutrient Type (Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals), By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027" report has been added to's offering.

The global parenteral nutrition market size is expected to reach $10.9 billion by 2027, rising at a market growth of 8.1% CAGR during the forecast period.

Parenteral nutrition (parenteral nutrition), or intravenous feeding, provides liquid nutrients such as proteins, vitamins, fats, electrolytes, minerals, and carbohydrates. It is a component of specialized nutritional therapy that renders nutritional support to patients who are not able to use their gastrointestinal tract properly. It is extremely helpful in eliminating malnutrition and maintaining hydration, energy, and strength levels. Due to this, it is broadly utilized among patients who are suffering from cancer, hydration, Crohn's disease, ischemic bowel disease, short bowel syndrome, and abnormal bowel function.

The development of the parenteral nutrition market is expected to be fueled by the surge in the occurrence of malnutrition among children, mainly in the emerging and under-developed nations around the globe. Additionally, the requirement for parenteral nutrition (parenteral nutrition) to appropriately balance amino acids, lipids, vitamins, minerals, and other nutrients is expected to create bright growth prospects for the growth of the parenteral nutrition market.

The adoption of parenteral nutrition is expected to fuel as it reduces the chances of underdevelopment and infection. Very-Low-Birth-Weight (VLBW) newborns are witnessing a huge demand for parenteral nutrition products due to the low possibility of Enteral Nutrition (EN). Additionally, a surge in the acceptance of parenteral nutrition for premature infants that results in better neurological growth enhanced intrauterine nutrient deposition, and lower chances of complications, hence enhancing their possibility of survival.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic has substantially boosted the adoption rate of parenteral nutrition to offer the required nutrition and fluids needed by the body for rapid and safe recovery. In addition, the increasing acceptance of the administration of nutrition by the parenteral medium as compared to enteral feeding among the patients suffering from the COVID-19 for fulfilling the required nutritional needs, rising nutrient absorption, and declining infection risk is expected to accelerate the demand & growth of the overall parenteral nutrition market in the upcoming years.

Moreover, the rising adoption of these formulations among the clinicians for assisting the patients to fulfill their target nutrition consumption, enhance recovery, and cut down the hospital stays are some of the factors propelling the development of the global parenteral nutrition market.

Market Growth Factors:

The surge in the rate of malnutrition among the global population

In addition, the governments of numerous countries are undertaking various initiatives with an aim to cut down the growing burden of malnutrition, hence increased the intravenous feeding demand. Various government organizations such as Action against Hunger, Food4Africa, Heifer International, and World Health Organization are willing to take new initiatives that aim to offer better treatment for malnourished individuals.

Higher prevalence of different chronic diseases

Various kinds of diseases like head & neck cancer, esophageal cancer, Crohn's, ulcerative colitis, gastric cancer, and laryngeal cancer can have an impact on oral food consumption among the patients. Due to their increasing occurrence, the global parenteral nutrition market is expected to be propelled in the upcoming years.

Market Restraining Factor:

Increasing inclination toward enteral nutrition

The preference toward enteral nutrition is constantly increasing among patients across the globe. Medical specialists generally suggest the use of enteral feeding in comparison to parenteral feeding. This is due to the fact that it is less expensive, can be easily administered, and have fewer complications. Moreover, enteral feeding enables better and effective nutrient consumption and supports the natural healing process of the body through the stimulation of the intestinal blood flow.

Nutrient Type Outlook

Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. The parenteral lipid emulsion segment is expected to exhibit the fastest growth rate during the forecasting period. Growing occurrences of hospital malnutrition is the main factor boosting the demand for parenteral lipid emulsions in giving non-protein calories and essential fatty acids in patients, decreasing inflammation, and enhancing metabolic & clinical outcomes. Additionally, the demand of the segment in hospitals is expected to be boosted by the increasing demand from severely suffering patients and the high rates of chronic diseases such as inflammatory bowel disease, cancer, and diabetes.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific is expected to display the fastest growth rate during the forecasting period. The regional market is expected to be boosted by the economic growth in different nations like India, Japan, and China and the supportive government initiatives along with the favorable reimbursement policies and growth of the healthcare industry. Additionally, the surge in the occurrence of chronic diseases, the rising awareness regarding the advantages of the nutrient types, and the growing number of parenteral nutrition users in some of the emerging countries of this region is expected to create new growth avenues for the players operating in the regional parenteral nutrition market over the forecast years.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.

Key Topics Covered:

Chapter 1. Market Scope & Methodology

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview COVID-19 Impact Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Parenteral Nutrition Market by Nutrient Type
3.1 Global Single Dose Amino Acid Solution Market by Region
3.2 Global Parenteral Lipid Emulsion Market by Region
3.3 Global Carbohydrates Market by Region
3.4 Global Trace Elements Market by Region
3.5 Global Other Nutrient Type Market by Region

Chapter 4. Global Parenteral Nutrition Market by Region

Chapter 5. Company Profiles
5.1 Vifor Pharma Management Ltd.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Research & Development Expenses
5.2 Baxter International, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments: Partnerships, Collaborations, and Agreements: Product Launches and Product Expansions: Approvals and Trails:
5.3 Allergan PLC (AbbVie)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expense
5.4 B. Braun Melsungen AG
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expenses
5.5 Fresenius SE & Co. KGaA
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.6 Grifols S.A.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.7 Pfizer, Inc.
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Regional Analysis
5.7.4 Research & Development Expenses
5.8 ICU Medical, Inc.
5.8.1 Company Overview
5.8.2 Recent strategies and developments: Partnerships, Collaborations, and Agreements:
5.9 Anhui Medipharm Co., Ltd.
5.9.1 Company Overview
5.10. Aculife Healthcare Private Limited
5.10.1 Company Overview

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting